Involvement of SIRT1 in hypoxic down-regulation of c-Myc and β-catenin and hypoxic preconditioning effect of polyphenols

Toxicology and Applied Pharmacology

Volumn 259, Issue 2, 2012, Pages 210-218

  Hong, Kyung Soo ^a   Park, Jun Ik ^a   Kim, Mi Ju ^a   Kim, Hak Bong ^a   Lee, Jae Won ^a   Dao, Trong Tuan ^b   Oh, Won Keun ^b   Kang, Chi Dug ^a   Kim, Sun Hee ^a  

^a Pusan National University School of Medicine   (South Korea)

^b Chosun University   (South Korea)

Author keywords

catenin; C Myc; HIF 1 ; Hypoxia; Polyphenols; SIRT1

Indexed keywords

BETA CATENIN; CASPASE 3; DEFEROXAMINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MYC PROTEIN; MYRICETIN; PICEATANNOL; POLYPHENOL DERIVATIVE; PROTEIN P21; QUERCETIN; RESVERATROL; SIRTUIN 1; VASCULOTROPIN;

ACETYLATION; APOPTOSIS; ARTICLE; CELL PROTECTION; CELL SURVIVAL; DEACETYLATION; DOWN REGULATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; ISCHEMIC PRECONDITIONING; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN STABILITY; RED WINE; REOXYGENATION; SIGNAL TRANSDUCTION; UPREGULATION;

ACETYLATION; BETA CATENIN; CELL HYPOXIA; DOWN-REGULATION; HEP G2 CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; POLYPHENOLS; PROTO-ONCOGENE PROTEINS C-MYC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SIRTUIN 1; UP-REGULATION;

EID: 84862832742     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2011.12.025     Document Type: Article

References (53)

1. Ameln A.K., Muschter A., Mamlouk S., Kalucka J., Prade I., Franke K., Rezaei M., Poitz D.M., Breier G., Wielockx B. Inhibition of HIF prolyl hydroxylase-2 blocks tumor growth in mice through the antiproliferative activity of TGFbeta. Cancer Res. 2011, 71:3306-3316.
2. Anastasiou D., Krek W. SIRT1: linking adaptive cellular responses to aging-associated changes in organismal physiology. Physiology (Bethesda) 2006, 21:404-410.
3. Berra E., Roux D., Richard D.E., Pouyssegur J. Hypoxia-inducible factor-1 alpha (HIF-1 alpha) escapes O(2)-driven proteasomal degradation irrespective of its subcellular localization: nucleus or cytoplasm. EMBO Rep. 2001, 2:615-620.
4. Brahimi-Horn C., Mazure N., Pouyssegur J. Signalling via the hypoxia-inducible factor-1alpha requires multiple posttranslational modifications. Cell. Signal. 2005, 17:1-9.
5. Brunet A., Sweeney L.B., Sturgill J.F., Chua K.F., Greer P.L., Lin Y., Tran H., Ross S.E., Mostoslavsky R., Cohen H.Y., Hu L.S., Cheng H.L., Jedrychowski M.P., Gygi S.P., Sinclair D.A., Alt F.W., Greenberg M.E. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004, 303:2011-2015.
6. Carmeliet P., Dor Y., Herbert J.M., Fukumura D., Brusselmans K., Dewerchin M., Neeman M., Bono F., Abramovitch R., Maxwell P., Koch C.J., Ratcliffe P., Moons L., Jain R.K., Collen D., Keshert E. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 1998, 394:485-490.
7. Chan D.A., Giaccia A.J. PHD2 in tumour angiogenesis. Br. J. Cancer 2010, 103:1-5.
8. Chen R., Dioum E.M., Hogg R.T., Gerard R.D., Garcia J.A. Hypoxia increases sirtuin 1 expression in a hypoxia-inducible factor-dependent manner. J. Biol. Chem. 2011, 286:13869-13878.
9. Chung S., Yao H., Caito S., Hwang J.W., Arunachalam G., Rahman I. Regulation of SIRT1 in cellular functions: role of polyphenols. Arch. Biochem. Biophys. 2010, 501:79-90.
10. Cohen H.Y., Lavu S., Bitterman K.J., Hekking B., Imahiyerobo T.A., Miller C., Frye R., Ploegh H., Kessler B.M., Sinclair D.A. Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis. Mol. Cell 2004, 13:627-638.
11. de Boer V.C., de Goffau M.C., Arts I.C., Hollman P.C., Keijer J. SIRT1 stimulation by polyphenols is affected by their stability and metabolism. Mech. Ageing Dev. 2006, 127:618-627.
12. Della-Morte D., Dave K.R., DeFazio R.A., Bao Y.C., Raval A.P., Perez-Pinzon M.A. Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway. Neuroscience 2009, 159:993-1002.
13. Demidenko Z.N., Rapisarda A., Garayoa M., Giannakakou P., Melillo G., Blagosklonny M.V. Accumulation of hypoxia-inducible factor-1alpha is limited by transcription-dependent depletion. Oncogene 2005, 24:4829-4838.
14. Dewhirst M.W. Intermittent hypoxia furthers the rationale for hypoxia-inducible factor-1 targeting. Cancer Res. 2007, 67:854-855.
15. Dioum E.M., Chen R., Alexander M.S., Zhang Q., Hogg R.T., Gerard R.D., Garcia J.A. Regulation of hypoxia-inducible factor 2alpha signaling by the stress-responsive deacetylase sirtuin 1. Science 2009, 324:1289-1293.
16. Ellis L., Hammers H., Pili R. Targeting tumor angiogenesis with histone deacetylase inhibitors. Cancer Lett. 2009, 280:145-153.
17. Firestein R., Blander G., Michan S., Oberdoerffer P., Ogino S., Campbell J., Bhimavarapu A., Luikenhuis S., de Cabo R., Fuchs C., Hahn W.C., Guarente L.P., Sinclair D.A. The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PLoS One 2008, 3:e2020.
18. Gan L., Mucke L. Paths of convergence: sirtuins in aging and neurodegeneration. Neuron 2008, 58:10-14.
19. Guarente L. Cell biology. Hypoxic hookup. Science 2009, 324:1281-1282.
20. Huang L.E. Carrot and stick: HIF-alpha engages c-Myc in hypoxic adaptation. Cell Death Differ. 2008, 15:672-677.
21. Huang L.E., Arany Z., Livingston D.M., Bunn H.F. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J. Biol. Chem. 1996, 271:32253-32259.
22. 2 sensing. Science 2001, 292:464-468.
23. Jeong J.W., Bae M.K., Ahn M.Y., Kim S.H., Sohn T.K., Bae M.H., Yoo M.A., Song E.J., Lee K.J., Kim K.W. Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation. Cell 2002, 111:709-720.
24. Jian B., Yang S., Chen D., Chaudry I., Raju R. Influence of aging and hemorrhage injury on Sirt1 expression: possible role of myc-Sirt1 regulation in mitochondrial function. Biochim. Biophys. Acta 2011, 1812:1446-1451.
25. Kaidi A., Williams A.C., Paraskeva C. Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat. Cell Biol. 2007, 9:210-217.
26. Kallio P.J., Pongratz I., Gradin K., McGuire J., Poellinger L. Activation of hypoxia-inducible factor 1alpha: posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:5667-5672.
27. Ke Q., Costa M. Hypoxia-inducible factor-1 (HIF-1). Mol. Pharmacol. 2006, 70:1469-1480.
28. Kim M.S., Kwon H.J., Lee Y.M., Baek J.H., Jang J.E., Lee S.W., Moon E.J., Kim H.S., Lee S.K., Chung H.Y., Kim C.W., Kim K.W. Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat. Med. 2001, 7:437-443.
29. Kwon H.S., Ott M. The ups and downs of SIRT1. Trends Biochem. Sci. 2008, 33:517-525.
30. Lee P.J., Jiang B.H., Chin B.Y., Iyer N.V., Alam J., Semenza G.L., Choi A.M. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J. Biol. Chem. 1997, 272:5375-5381.
31. Lee K.A., Roth R.A., LaPres J.J. Hypoxia, drug therapy and toxicity. Pharmacol. Ther. 2007, 113:229-246.
32. Levy L., Wei Y., Labalette C., Wu Y., Renard C.A., Buendia M.A., Neuveut C. Acetylation of beta-catenin by p300 regulates beta-catenin-Tcf4 interaction. Mol. Cell. Biol. 2004, 24:3404-3414.
33. Lim J.H., Chun Y.S., Park J.W. Hypoxia-inducible factor-1alpha obstructs a Wnt signaling pathway by inhibiting the hARD1-mediated activation of beta-catenin. Cancer Res. 2008, 68:5177-5184.
34. Lim J.H., Lee Y.M., Chun Y.S., Chen J., Kim J.E., Park J.W. Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. Mol. Cell 2010, 38:864-878.
35. Liu T., Liu P.Y., Marshall G.M. The critical role of the class III histone deacetylase SIRT1 in cancer. Cancer Res. 2009, 69:1702-1705.
36. Manalo D.J., Rowan A., Lavoie T., Natarajan L., Kelly B.D., Ye S.Q., Garcia J.G., Semenza G.L. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 2005, 105:659-669.
37. Mao B., Zhao G., Lv X., Chen H.Z., Xue Z., Yang B., Liu D.P., Liang C.C. Sirt1 deacetylates c-Myc and promotes c-Myc/Max association. Int. J. Biochem. Cell Biol. 2011, 43:1573-1581.
38. Motta M.C., Divecha N., Lemieux M., Kamel C., Chen D., Gu W., Bultsma Y., McBurney M., Guarente L. Mammalian SIRT1 represses forkhead transcription factors. Cell 2004, 116:551-563.
39. Oh W.K., Cho K.B., Hien T.T., Kim T.H., Kim H.S., Dao T.T., Han H.K., Kwon S.M., Ahn S.G., Yoon J.H., Kim Y.G., Kang K.W. Amurensin G, a potent natural SIRT1 inhibitor, rescues doxorubicin responsiveness via down-regulation of multidrug resistance 1. Mol. Pharmacol. 2010, 78:855-864.
40. Piret J.P., Minet E., Cosse J.P., Ninane N., Debacq C., Raes M., Michiels C. Hypoxia-inducible factor-1-dependent overexpression of myeloid cell factor-1 protects hypoxic cells against tert-butyl hydroperoxide-induced apoptosis. J. Biol. Chem. 2005, 280:9336-9344.
41. Rane S., He M., Sayed D., Vashistha H., Malhotra A., Sadoshima J., Vatner D.E., Vatner S.F., Abdellatif M. Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ. Res. 2009, 104:879-886.
42. Raval A.P., Dave K.R., Perez-Pinzon M.A. Resveratrol mimics ischemic preconditioning in the brain. J. Cereb. Blood Flow Metab. 2006, 26:1141-1147.
43. Salceda S., Caro J. Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J. Biol. Chem. 1997, 272:22642-22647.
44. Saunders L.R., Verdin E. Sirtuins: critical regulators at the crossroads between cancer and aging. Oncogene 2007, 26:5489-5504.
45. Schofield C.J., Ratcliffe P.J. Oxygen sensing by HIF hydroxylases. Nat. Rev. Mol. Cell Biol. 2004, 5:343-354.
46. 2 homeostasis. Curr. Opin. Genet. Dev. 1998, 8:588-594.
47. Semenza G.L. Regulation of physiological responses to continuous and intermittent hypoxia by hypoxia-inducible factor 1. Exp. Physiol. 2006, 91:803-806.
48. Sermeus A., Cosse J.P., Crespin M., Mainfroid V., de Longueville F., Ninane N., Raes M., Remacle J., Michiels C. Hypoxia induces protection against etoposide-induced apoptosis: molecular profiling of changes in gene expression and transcription factor activity. Mol. Cancer 2008, 7:27.
49. Yang X.J., Gregoire S. Class II histone deacetylases: from sequence to function, regulation, and clinical implication. Mol. Cell. Biol. 2005, 25:2873-2884.
50. Yeung F., Hoberg J.E., Ramsey C.S., Keller M.D., Jones D.R., Frye R.A., Mayo M.W. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 2004, 23:2369-2380.
51. Ying W. NAD+/NADH and NADP+/NADPH in cellular functions and cell death: regulation and biological consequences. Antioxid. Redox Signal. 2008, 10:179-206.
52. Yu E.Z., Li Y.Y., Liu X.H., Kagan E., McCarron R.M. Antiapoptotic action of hypoxia-inducible factor-1 alpha in human endothelial cells. Lab. Invest. 2004, 84:553-561.
53. Yuan J., Minter-Dykhouse K., Lou Z. A c-Myc-SIRT1 feedback loop regulates cell growth and transformation. J. Cell Biol. 2009, 185:203-211.